GlassScriptPhysician profile
Thomas M Sajda
NPI 1215497086
$11,211.14
in general payments reported to CMS, 2019-2025
13 companies · $5,883 in 2025
The $5,883 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $5,328 · 2025: $5,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,211.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,263.99 | 2024-2025 | Real Intelligence, Legion |
| Depuy Synthes Sales INC. | $176.82 | 2024-2025 | Na, Tfn-Advance, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $171.94 | 2025 | Hammr Curved G7 Impactor, G7, Z1 Hip System |
| Stryker Corporation | $166.85 | 2025 | Variax, Tornier Perform Reversed Glenoid, Insignia |
| Solventum Corporation | $141.63 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Arthrex, INC. | $84.90 | 2025 | |
| Amgen INC. | $51.92 | 2025 | Evenity |
| Orthalign INC | $34.43 | 2025 | Orthalign Plus |
| Omnilife Science, INC | $33.69 | 2025 | |
| Djo, LLC | $28.68 | 2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $26.09 | 2024 | |
| Radius Health, INC. | $17.08 | 2024 | Tymlos |
| Bioventus LLC | $13.12 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Sajda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.